文献速递心外重症与机械循环支持

短期机械循环支持作为顽固性心源性休克患者桥接至耐久性左心室辅助装置植入的系统综述与荟萃分析

Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2017-01-01

不同装置的平均支持时长为1.6-25天,出院患者比例平均为45-66%,桥接至耐久性LVAD的平均比例为3-30%,在终末期心肌病患者中最常见(22% [12-35%])。结论认为临时MCS可用于将心源性休克患者桥接至耐久性LVAD。

要点

  • 短期MCS可作为心源性休克患者桥接至耐久性LVAD的策略。
  • 不同装置支持时长1.6-25天,出院比例45-66%。
  • 桥接至耐久性LVAD比例3-30%,终末期心肌病患者中最常见。

核心结论

  • 临时MCS可用于将心源性休克患者桥接至耐久性LVAD。

主要发现

  • 根据装置不同(IABP、TandemHeart、Impella 2.5、Impella 5.0、CentriMag和外周VA-ECMO),平均支持时长为1.6-25天。
  • 短期MCS患者出院比例平均为45-66%。
  • 桥接至耐久性LVAD的平均比例为3-30%。
  • 桥接至耐久性LVAD在终末期心肌病患者中最常见,比例为22% [12-35%]。

关键数值与推荐

  • 纳入标准:因急性心肌梗死、终末期心肌病或急性心肌炎导致心源性休克并接受短期MCS的患者。
  • 排除标准:围手术期、心脏术后和心肺复苏支持的研究。

临床怎么用

  • 临床医生可考虑使用临时MCS将心源性休克患者桥接至耐久性LVAD。
  • 鼓励临床医生在多中心大型注册研究中分享结果,以研究最佳装置选择和最佳支持时长。

局限性

  • 纳入研究主要为注册研究,患者群体异质性大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Short-term mechanical circulatory support (MCS) is increasingly used as a bridge to decision in patients with refractory cardiogenic shock. Subsequently, these patients might be bridged to durable MCS either as a bridge to candidacy/transplantation, or as destination therapy. The aim of this study was to review support duration and clinical outcome of short-term MCS in cardiogenic shock, and to analyse application of this technology as a bridge to long-term cardiac support (left ventricular assist device, LVAD) from 2006 till June 2016. Using Cochrane Register of Trials, Embase and Medline, a systematic review was performed on patients with cardiogenic shock from acute myocardial infarction, end-stage cardiomyopathy, or acute myocarditis, receiving short-term MCS. Studies on periprocedural, post-cardiotomy and cardiopulmonary resuscitation support were excluded. Thirty-nine studies, mainly registries of heterogeneous patient populations (n = 4151 patients), were identified. Depending on the device used (intra-aortic balloon pump, TandemHeart, Impella 2.5, Impella 5.0, CentriMag and peripheral veno-arterial extracorporeal membrane oxygenation), mean support duration was (range) 1.6-25 days and the mean proportion of short-term MCS patients discharged was (range) 45-66%. The mean proportion of bridge to durable LVAD was (range) 3-30%. Bridge to durable LVAD was most frequently performed in patients with end-stage cardiomyopathy (22 [12-35]%). We conclude that temporary MCS can be used to bridge patients with cardiogenic shock towards durable LVAD. Clinicians are encouraged to share their results in a large multicentre registry in order to investigate optimal device selection and best duration of support.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. den Uil CA, Akin S, Jewbali LS, et al. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2017. PMID: 28472406. doi:10.1093/ejcts/ezx088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。